Granted Patent
Utility
US 6,576,669 · App. 10/050,409
Use of an LTB4 antagonist for the treatment or prevention of diseases caused by increased expression of mucin genes
Inventors:
Ralf Anderskewitz, Christopher Meade, Franz Birke, Hans Michael Jennewein, Birgit Jung
Patented Case
View Patent ↗
Granted: Jun 10, 2003
Filed: Jan 16, 2002
Inventors
Ralf Anderskewitz
Christopher Meade
Franz Birke
Hans Michael Jennewein
Birgit Jung
Assignee (at issue)
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
This patent predates the USPTO's electronic file wrapper — prosecution documents from this era exist only in the Patent Office's paper records. A certified copy of the file history can be ordered from the USPTO's paper archives.